Over £250K is being invested in MAHSC Clinical Trials Unit (MAHSC-CTU) by Health Innovation Manchester this year, in recognition of its strategic importance within Greater Manchester’s clinical research infrastructure.
The CTU, with two operational branches at The University of Manchester and The Christie, provides a wide range of services supporting investigator-initiated clinical trials across the region and the UK.
Health Innovation Manchester (HInM)’s 2017 Business Plan recognizes MAHSC-CTU’s vital role in delivering against its clinical research excellence strategic priority work stream. The intention is for the CTU to be ideally positioned to support the next generation of clinical trials, including real world trials.
The HInM money is being used for CTU core infrastructure staffing and an improved database to accelerate clinical trials delivery.
Over the last few months the MAHSC-CTU has undergone major organisational and financial changes to increase efficiency and capacity. As a result, the unit is fully open to new applications for trial support. Further details of the new trial adoption process can be found here
‘Since August 2016 we have been working to create a step-change in the CTU’s capabilities’ said Professor Kevin O’Brien, MAHSC-CTU Director. ‘This uplift, including an expansion of our senior leadership team, means we can fully service clinical studies including those arising out of the recent research funding successes in Manchester. This important funding from HInM allowed us to bring forward our improvement plans for the unit.’
Since November last year the following people have joined Professor O’Brien and Phil Barley (Associate Director – Operations) on the senior leadership team: Professor Juan Valle (Clinical Director – Oncology), Professor Richard Emsley (Deputy Director – Methodologies) and Professor Rachel Elliot (Chair in Health Economics).
The CTU is applying for re-registration as a UK Clinical Research Collaboration (UK CRC) Clinical Trials Unit. To gain UK CRC registration, CTUs must demonstrate a track record of experience in coordinating multi-centre trials, expert staff to develop studies, robust quality assurance systems and evidence of long-term viability of capacity for trials coordination.
MAHSC-CTU’s web presence is now hosted on the MAHSC website – click here for more information.
* Established by Greater Manchester Health and Social Care Partnership, Health Innovation Manchester (HInM) is an academic health science system dedicated to speeding up the discovery, development and delivery of cutting-edge health solutions for patients. It brings together the work of MAHSC and the GM AHSN with enhanced interaction with industry and commissioners.